Alpa Laboratories Share Price

₹ 52.97

+₹0.59 (1.13%)
1D
Last updated 03 Nov, 2026, 15:25 IST
NSE: ALPA
|
Pharmaceuticals

Alpa Laboratories Share Price Today

As of 4 Nov 2026, Alpa Laboratories share price is ₹52.97. The stock opened at ₹52.12, compared to its previous close of ₹52.38. During today's trading session, Alpa Laboratories share price moved in the range of ₹51.00 to ₹52.97, with an average price of ₹51.98 for the day. Looking at its last 52-week, the stock has touched a low of ₹46.10 and a high of ₹92.50.

Share price over the last 1 day fell from 52.99 to 52.97, ranging between 51.00 and 52.99.

₹51.00
1.13% up today
₹52.97
1D LOW
1D HIGH

Alpa Laboratories Stock Insights

Latest Earning
Op Profit TrendDown by 68.08% QoQ
Latest Earning
Net Profit TrendDown by 28.99% QoQ
Latest Earning
Revenue TrendDown by 4.93% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 33.71 % in last 1 yr
Alpa Laboratories stock performance
Open₹52.12
High₹52.97
Low₹51.00
Prev. close₹52.38
Alpa Laboratories trading activity
Volume4,695
Average traded price₹51.86
Last traded time03:25:49 03 Nov
Last traded quantity6

Circuit
L
H
₹41.44
₹62.16
52-week
L
H
₹46.10
₹92.50
Mkt Cap Cr
111.45

P/E
27.45

P/B
0.6

ROA
1.68%
ROE
8.06%

ROCE
8.98%

Quick Ratio
3.76

EV/EBITDA
12.45

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Alpa Laboratorie has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Alpa Laboratorie appears overvalued compared to its peers
Earnings: 1 out of 5, Very Poor
Earnings
Very Poor
Alpa Laboratorie revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,64,141.2490.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4784.09.64.7%11.42%11.37%0.7533.48
Laurus Labs1,26,811.2894.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,300.8316.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Alpa Laboratories Company Background

ISIN
INE385I01010
Sector Market Cap
₹ 111.45 Cr

Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.

Alpa Laboratories Financial Highlights

  • Revenue: Alpa Laboratories reported revenue of ₹121.57 crore in FY26 vs ₹135.80 crore in FY25. It showed a decrease of 10.48% on a yearly basis.
  • Operating Profit: Alpa Laboratories reported an operating profit of ₹16.70 crore in FY26 vs ₹25.67 crore in FY25. It showed a decrease of 34.94% on a year-on-year basis.
  • Net Profit: Alpa Laboratories reported a net profit of ₹15.01 crore in FY26 vs ₹19.50 crore in FY25. It showed a decrease of 23.03% on a yearly basis.

Alpa Laboratories Quarterly Result Highlights

  • Alpa Laboratories reported revenue of ₹29.70 crore in Jun 2026, compared with ₹31.24 crore in Mar 2026, representing a decrease of 4.93% on a quarter-on-quarter (QoQ) basis.
  • Alpa Laboratories reported an operating profit of ₹0.98 crore in Jun 2026, compared with ₹3.07 crore in Mar 2026, representing a decrease of 68.08% on a quarter-on-quarter (QoQ) basis.
  • Alpa Laboratories reported a profit of ₹0.98 crore in Jun 2026, compared with ₹1.38 crore in Mar 2026, reflecting a decrease of 28.99% on a QoQ basis.
  • The earnings per share (EPS) of Alpa Laboratories stood at ₹6.71 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
57.19%
FII
0.35%
Other DII
0.07%
Retail and other
42.39%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.36%
Mar 20260.38%
Jun 20260.35%
Sep 20260.35%

Alpa Laboratories Investment Returns

1 day
--

1 week
--

1 month
--

1 year
--

3 years
--

5 years
--

Alpa Laboratories Share Price History

Alpa Laboratories share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹52.12 / ₹51.80
-1.11%
02 Nov 26
₹50.38 / ₹52.38
+3.97%
30 Oct 26
₹51.50 / ₹50.38
-4.26%
29 Oct 26
₹51.00 / ₹52.62
+0.80%
Show more

Alpa Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹105.81₹112.45₹108.74₹92.96
Other Income₹15.76₹23.35₹14.89₹9.37
Total Revenue₹121.57₹135.80₹123.63₹102.32
Total Expenses₹104.87₹110.13₹102.95₹86.43
Profit Before Tax₹16.70₹25.67₹20.68₹15.89
Tax₹1.69₹6.16₹3.91₹3.31
Profit After Tax₹15.01₹19.50₹16.78₹12.58
EPS - Basic₹6.71₹9.34₹8.01₹5.88
EPS - Diluted₹6.71₹9.34₹8.01₹5.88

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹16.70₹25.82₹20.76₹15.68
Income before WC changes₹4.78₹10.10₹11.35₹13.30
Change in Assets₹4.00-₹11.56₹4.23-₹3.82
Change in Liabilities₹3.35₹23.84-₹8.29₹3.02
Change in WC₹7.35₹12.28-₹4.06-₹0.80
Cash flow from Operations₹9.29₹18.32₹3.65₹8.90
Cash flow from Investing-₹10.88-₹12.36-₹13.34₹2.13
Cash flow from Financing₹2.22-₹5.44₹2.58-₹3.79
Total Cash Flow₹0.63₹0.51-₹7.10₹7.24
Cash (Start of the year)₹3.62₹3.11₹10.21₹1.58
Cash (End of the year)₹4.25₹3.62₹3.11₹8.81

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹31.25₹30.14₹21.39₹18.14
Current Assets₹210.90₹192.49₹160.98₹149.13
Total Assets₹242.14₹222.63₹182.37₹167.27
Current Liabilities₹52.53₹46.70₹28.07₹29.63
Net Current Asset₹158.37₹145.79₹132.92₹119.50
Non-Current Liabilities₹3.34₹4.49₹2.40₹3.06
Equity Capital₹186.28₹171.43₹151.91₹134.58
Total Equity & Liabilities₹242.14₹222.63₹182.37₹167.27

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹105.81₹112.45₹108.74₹92.96
Other Income₹15.72₹23.31₹14.87₹9.41
Total Revenue₹121.53₹135.76₹123.61₹102.36
Total Expenses₹104.89₹109.92₹102.94₹86.43
Profit Before Tax₹16.64₹25.84₹20.67₹15.93
Tax₹1.69₹6.16₹3.90₹3.31
Profit After Tax₹14.95₹19.68₹16.78₹12.62
EPS - Basic₹6.69₹9.42₹8.01₹5.90
EPS - Diluted₹6.69₹9.42₹8.01₹5.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹16.64₹25.99₹20.76₹15.72
Income before WC changes₹5.45₹10.21₹10.90₹14.25
Change in Assets₹4.04-₹11.59₹1.72-₹3.66
Change in Liabilities₹3.30₹23.84-₹5.29₹3.20
Change in WC₹7.34₹12.25-₹3.57-₹0.46
Cash flow from Operations₹9.95₹18.39₹3.70₹10.20
Cash flow from Investing-₹11.58-₹12.49-₹13.45₹1.17
Cash flow from Financing₹1.16-₹5.48₹2.26-₹3.48
Total Cash Flow-₹0.47₹0.43-₹7.49₹7.89
Cash (Start of the year)₹3.08₹2.62₹10.14₹2.24
Cash (End of the year)₹2.61₹3.05₹2.66₹10.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹42.62₹41.53₹32.65₹29.29
Current Assets₹208.75₹191.45₹159.77₹148.80
Total Assets₹251.38₹232.98₹192.42₹178.09
Current Liabilities₹51.46₹46.69₹28.06₹29.92
Net Current Asset₹157.29₹144.77₹131.72₹118.88
Non-Current Liabilities₹3.34₹4.49₹2.40₹3.06
Equity Capital₹196.58₹181.80₹161.97₹145.11
Total Equity & Liabilities₹251.38₹232.98₹192.42₹178.09
* All values are in INR Crore
Alpa Laboratories market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Alpa Laboratories technical summary
Bearish indicators4
Neutral indicators4
Bullish indicators0
OverallStrong Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
42.17
Neutral

ATR (14)
3.16
Neutral

STOCH(9,6)
84.43
Bearish

STOCH RSI (14)
100
Bearish

ADX(9)
25.05
Bearish

UO(9)
50.38
Neutral

ROC(12)
-8.73
Bearish

WillR(14)
-54.49
Neutral
Period
Simple value
Exponential vaue

5D
52.11
52.11

10D
51.28
52.27

20D
53.77
53.71

50D
58.23
57.48

100D
62.94
60.81
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Alpa Laboratories
Pharmaceuticals
Add Stock
Add Another

Alpa Laboratories Returns Calculator

Alpa Laboratories Share Price FAQs











Please be aware that Alpa Laboratories stock prices are subject to continuous fluctuations due to various factors.